drugset / Trial / NCT01654302

Efficacy and Safety of Synera in Osteoarthritis Pain

NCT01654302

Phase 1/2 Completed 40 enrolled Thomas J. Schnitzer Nuvo Research Inc. · collab
RandomizedCrossoverTriple-blindTreatment

Summary

Knee osteoarthritis (OA) can result in significant pain and limitation of function. A number of topical non-steroidal anti-inflammatory drugs have been shown to reduce pain in this condition. This study examines a different topical approach, utilizing a topical anesthetic agent, to evaluate if application of such an agent would provide relief of exercise-induced knee pain in people with knee OA.

Timeline

Start
2013-09
Primary completion
2014-09
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 70 mg Topical
Subject tetracaine Other / unclassified 70 mg Topical

Indications